<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01565980</url>
  </required_header>
  <id_info>
    <org_study_id>CTSI grant</org_study_id>
    <nct_id>NCT01565980</nct_id>
  </id_info>
  <brief_title>Mindfulness Therapy for Individuals With Lung Cancer</brief_title>
  <official_title>A Mindfulness Intervention for Symptom Management in Lung Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Michigan State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Michigan State University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Managing psychological and physical symptoms to improve quality of life in patients with lung
      cancer are a major public health concern. Mindfulness-based therapies are showing promise in
      modifying psychological distress and improving quality of life in some cancer groups, but
      little testing has included lung cancer samples. Mindfulness-based therapies integrate
      meditation, breathing, and gentle yoga practices to promote an attitude of nonjudgmental
      acceptance and awareness of bodily states. Such strategies may promote well being,
      self-regulation, and symptom management. The study purpose was to test the acceptability,
      feasibility, and symptom / health-related quality of life (HRQOL) outcomes of a home-based
      mindfulness intervention for individuals with advanced lung cancer during non-curative
      treatment (radiation and/or chemotherapy). Acceptability and feasibility were measured via
      patient consent and retention rates, therapy expectancy, study adherence, attrition reasons,
      and quality assurance indicators. Efficacy was determined via symptom and HRQOL (health
      perceptions, physical and emotional function) outcomes. 40 patients undergoing treatment of
      non-small cell lung cancer were randomized to receive either six weekly mindfulness sessions
      (N=20) or an attention control condition (N=20). Outcome data was obtained at baseline (Time
      1), post-intervention (Time 2, week 8), and four weeks after completion (Time 3, week 11). In
      addition, both groups received weekly symptom assessment interviews. The hypothesis was that
      the mindfulness group would report better symptom management and HRQOL (lower worry, dyspnea,
      insomnia, depression; higher physical and social function; more positive health perceptions)
      than the attention control group at the protocol end and that these differences will be
      sustained at Time 3.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The final sample (n = 32) included 16 patients in the intervention and 16 in the attention
      control group (study attrition (n = 8, 20%).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Actual">June 2013</completion_date>
  <primary_completion_date type="Actual">June 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>M.D. Anderson Symptom Inventory (MDASI)</measure>
    <time_frame>Time 2 (week 8), Time 3 (week 11), and overall average for group comparisons.</time_frame>
    <description>Symptom Severity and interference were measured with the M.D. Anderson Symptom Inventory (MDASI) . The MDASI is a multisymptom patient-reported outcome measure. The MDASI has 13 core items include symptoms found to have the highest frequency and/or severity in patients with various cancers and treatment types (pain, fatigue, nausea, vomiting, disturbed sleep, distress, shortness of breath, memory difficulties, lack of appetite, drowsiness, dry mouth, sadness,numbness and tingling. Patients rate the severity of each symptom &quot;at its worst&quot; using 0-10 numerical rating scales with 0 = &quot;not present&quot; and 10 = &quot;as bad as you can imagine.&quot; The measure includes 5 symptom interference items which ask how much all symptoms, interfere with domains (walking, work, general activity, mood, relations with others, enjoyment of life) also rated on a 0-10 scale (0 = &quot;did not interfere&quot;; 10 = &quot;interfered completely&quot;). The 13 severity (range 0 - 130) and 5 interference items (range 0 - 50) are summed.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>SF-36</measure>
    <time_frame>Time 2 (week 8), Time 3 (week 11), and overall average for group comparisons.</time_frame>
    <description>Health-related Quality of Life (HRQOL) Indices (Physical/Emotional Function, Role Function, Pain, General Health, Vitality, Mental/Physical Health)HRQOL(SF-36) calculated using Quality Metric, Inc. an algorithm producing normal scores (1-100 range). With normed scoring, general population has mean=50, SD=10. For the minimum and maximum values in each of the scale ranges provided, higher values represent a better outcome.</description>
  </primary_outcome>
  <other_outcome>
    <measure>Center for Epidemiologic Studies Depression (CES-D)</measure>
    <time_frame>Time 2 (week 8), Time 3 (week 11), and overall average for group comparisons.</time_frame>
    <description>The score is the sum of the 20 questions. Each item has a range of 1 - 4 for frequency of a behavior or mental state in the past week ; 1 - Rarely or none of the time (less than 1 day); 2 = Some or a little of the time (1-2 days); 3 = Occasionally or a moderate amount of time (3-4 days); 4 = Most or all of the time (5-7 days). Possible range is 0-60. There are 4 reverse-scored items (questions 4, 8, 12, and 16). A score of 16 points or more is considered depressed.</description>
  </other_outcome>
  <other_outcome>
    <measure>Cancer Dyspnea Scale</measure>
    <time_frame>Time 2 (week 8), Time 3 (week 11), and overall average for group comparisons.</time_frame>
    <description>The cancer dyspnea scale (CDS) has 12 Likert scale items ( 1 = Not at all, 5 = Very much) that ask questions about breathlessness or difficulty in breathing during the past few days. The CDS has an overall score (range 0-42) and 3 subscales that measure the amount of effort with breathing, anxiety associated with breathing, and discomfort associated with breathing.
The 3 subscales are calculated by: 1) effort (items 4+6+8+10+12) - 5 [range 0 (no dyspnea effort)-20 (worst dyspnea effort)]; 2) anxiety (items 5+7+9+11) - 4 [range 0 (no dyspnea anxiety) - 16 (worst dyspnea anxiety)]; 3) discomfort [15 - (items 1+2+3) {range 0 (no dyspnea discomfort) - 12 (worst dyspnea discomfort)}]. The total dyspnea score is derived by adding the total subscale scores. The subscale score subtractions are to make adjustments for 0 as a state of absence of dyspnea (thus total dyspnea summary scores range from 0 to 42).</description>
  </other_outcome>
  <other_outcome>
    <measure>Worry (Cancer-related and General)</measure>
    <time_frame>Time 2 (week 8), Time 3 (week 11), and overall average for group comparisons.</time_frame>
    <description>Both cancer-related and general worry were measured with 3 item scales. Cancer-related worry had three statements asking about level of worry related to diagnosis, treatment, and worry interference using a 1 = &quot;not at all&quot; to 5 = &quot;most or all the time&quot; scale, range 3-15. Items are summed. General worry used an abbreviated brief Penn State Worry questionnaire with 3 statements that measure how typical that statements are in describing the person. Uses a 3 item scale with 1 = &quot;not at all typical&quot; to 5 = &quot;very typical&quot;. the range is 3-15. Items are summed.</description>
  </other_outcome>
  <other_outcome>
    <measure>Pittsburgh Sleep Symptom Questionnaire-Insomnia (PSSQ_I)</measure>
    <time_frame>Time 2 (week 8), Time 3 (week 11), and overall average for group comparisons.</time_frame>
    <description>The PSSQ_I has 13 self rated questions. The first 5 items, used to determine sleep quality (presence; frequency of insomnia problems) are rated [0 = never to 5 = always, 5-7 days per week; (range 0-25)] and items 6 to 13 are aimed at identifying the degree of interference experienced from sleep impairment (rated 0=not at all to 4=extremely on Likert scale; range 0 - 32).</description>
  </other_outcome>
  <other_outcome>
    <measure>Baseline Values for All Measures.</measure>
    <time_frame>Baseline.</time_frame>
    <description>Description of all measures are described elsewhere. Provided are the means and standard deviations for baseline comparisons.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Lung Cancer</condition>
  <arm_group>
    <arm_group_label>symptom assessment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>6 weeks of symptom assessment phone calls.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mindfulness intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants receive 6 weeks of the home-based mindfulness intervention, and weekly symptom assessment phone calls.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>symptom assessment</intervention_name>
    <description>attention control receives a weekly symptom assessment phone interview for 6 weeks.</description>
    <arm_group_label>symptom assessment</arm_group_label>
    <arm_group_label>Mindfulness intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Mindfulness Intervention</intervention_name>
    <description>Participants will receive a weekly home-based mindfulness intervention, and symptom assessment phone interviews for 6 weeks.</description>
    <arm_group_label>Mindfulness intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Able to understand and speak English

          2. at least 21 years old

          3. active treatment for a diagnosis of non-small cell lung cancer

          4. Karnofsky score &gt; 80

          5. have a telephone by which they can be reached

        Exclusion Criteria:

          1. current substance abuse other than tobacco

          2. active treatment for psychiatric disorders excluding depression, and/or use of
             antipsychotic medications that would impede study participation.

          3. cognitive impairment

          4. active participation in mindfulness-based classes, guided imagery, yoga, or relaxation
             therapy courses

          5. diagnosis of small cell lung cancer
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rebecca Lehto, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Michigan State University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60208</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Michigan State University</name>
      <address>
        <city>East Lansing</city>
        <state>Michigan</state>
        <zip>48824</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Allegiance Health</name>
      <address>
        <city>Jackson</city>
        <state>Michigan</state>
        <zip>49201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 22, 2012</study_first_submitted>
  <study_first_submitted_qc>March 27, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 29, 2012</study_first_posted>
  <results_first_submitted>July 13, 2014</results_first_submitted>
  <results_first_submitted_qc>November 14, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">November 17, 2014</results_first_posted>
  <last_update_submitted>November 14, 2014</last_update_submitted>
  <last_update_submitted_qc>November 14, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 17, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Michigan State University</investigator_affiliation>
    <investigator_full_name>Rebecca Lehto</investigator_full_name>
    <investigator_title>PhD, RN, Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Lung cancer</keyword>
  <keyword>mindfulness therapy</keyword>
  <keyword>active treatment (radiation and/or chemotherapy)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Patients were recruited from two community-based hospital sites and one cancer center located in Chicago Illinois. Recruitment occurred between March 2012 to February 2013.</recruitment_details>
      <pre_assignment_details>There were no participants excluded from the trial before group assignment. However, there were patients who dropped from the study before starting the intervention.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Symptom Assessment</title>
          <description>weekly phone calls.
symptom assessment: attention control group</description>
        </group>
        <group group_id="P2">
          <title>Mindfulness Intervention</title>
          <description>Participants will receive 6 weeks of home-based mindfulness intervention.
Mindfulness Intervention: Participants will receive a weekly home-based mindfulness intervention.
Participants also receive weekly symptom assessment phone interview.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="20">Three patients had started the intervention protocol at the time of study withdrawal.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
                <participants group_id="P2" count="16"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>health complications</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>stopped medical treatment</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Attention Control</title>
          <description>weekly symptom assessment phone calls.</description>
        </group>
        <group group_id="B2">
          <title>Mindfulness Intervention</title>
          <description>Participants receive weekly symptom assessment phone calls.
Mindfulness Intervention: Participants receive 6 weekly sessions of a home delivered mindfulness intervention.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="20"/>
            <count group_id="B2" value="20"/>
            <count group_id="B3" value="40"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="67.9" spread="9.5"/>
                    <measurement group_id="B2" value="64.5" spread="9.25"/>
                    <measurement group_id="B3" value="66.2" spread="9.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>American Indian or Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native Hawaiian or Other Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>More than one race</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>M.D. Anderson Symptom Inventory (MDASI)</title>
        <description>Symptom Severity and interference were measured with the M.D. Anderson Symptom Inventory (MDASI) . The MDASI is a multisymptom patient-reported outcome measure. The MDASI has 13 core items include symptoms found to have the highest frequency and/or severity in patients with various cancers and treatment types (pain, fatigue, nausea, vomiting, disturbed sleep, distress, shortness of breath, memory difficulties, lack of appetite, drowsiness, dry mouth, sadness,numbness and tingling. Patients rate the severity of each symptom “at its worst” using 0–10 numerical rating scales with 0 = “not present” and 10 = “as bad as you can imagine.” The measure includes 5 symptom interference items which ask how much all symptoms, interfere with domains (walking, work, general activity, mood, relations with others, enjoyment of life) also rated on a 0-10 scale (0 = &quot;did not interfere&quot;; 10 = &quot;interfered completely&quot;). The 13 severity (range 0 - 130) and 5 interference items (range 0 - 50) are summed.</description>
        <time_frame>Time 2 (week 8), Time 3 (week 11), and overall average for group comparisons.</time_frame>
        <population>Adjusted means of outcomes and their standard errors are reported for times 2 and 3. The summary of linear mixed effects for group comparisons are then presented.</population>
        <group_list>
          <group group_id="O1">
            <title>Attention Control Group</title>
            <description>weekly phone calls.
symptom assessment interview.</description>
          </group>
          <group group_id="O2">
            <title>Mindfulness Intervention</title>
            <description>Participants receive 6 weekly sessions of a home delivered mindfulness intervention.
Participants receive weekly phone calls to assess symptoms.</description>
          </group>
        </group_list>
        <measure>
          <title>M.D. Anderson Symptom Inventory (MDASI)</title>
          <description>Symptom Severity and interference were measured with the M.D. Anderson Symptom Inventory (MDASI) . The MDASI is a multisymptom patient-reported outcome measure. The MDASI has 13 core items include symptoms found to have the highest frequency and/or severity in patients with various cancers and treatment types (pain, fatigue, nausea, vomiting, disturbed sleep, distress, shortness of breath, memory difficulties, lack of appetite, drowsiness, dry mouth, sadness,numbness and tingling. Patients rate the severity of each symptom “at its worst” using 0–10 numerical rating scales with 0 = “not present” and 10 = “as bad as you can imagine.” The measure includes 5 symptom interference items which ask how much all symptoms, interfere with domains (walking, work, general activity, mood, relations with others, enjoyment of life) also rated on a 0-10 scale (0 = &quot;did not interfere&quot;; 10 = &quot;interfered completely&quot;). The 13 severity (range 0 - 130) and 5 interference items (range 0 - 50) are summed.</description>
          <population>Adjusted means of outcomes and their standard errors are reported for times 2 and 3. The summary of linear mixed effects for group comparisons are then presented.</population>
          <units>units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Symptom Severity - Time 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33.91" spread="3.94"/>
                    <measurement group_id="O2" value="20.91" spread="4.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Symptom Severity - Time 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33.04" spread="3.98"/>
                    <measurement group_id="O2" value="22.86" spread="4.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Symptom Severity - Summary</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32.11" spread="2.64"/>
                    <measurement group_id="O2" value="26.79" spread="2.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Symptom Interference - Time 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.38" spread="2.63"/>
                    <measurement group_id="O2" value="10.45" spread="2.88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Symptom Interference - Time 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.27" spread="2.65"/>
                    <measurement group_id="O2" value="11.06" spread="2.90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Symptom Interference - Summary</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.95" spread="1.74"/>
                    <measurement group_id="O2" value="4.33" spread="1.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The outcome measure was analyzed using linear mixed effects models (LME). The main effect of the trial arm was evaluated by averaging time 2 and time 3 values of the outcomes within the LME model. The resulting least square (LS) means and their standard errors are reported.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;.05</p_value>
            <p_value_desc>P-values for the comparison of least square (LS) means represent the effect of the trial arm. The effect sizes are calculated as Cohen’s d: difference between LS means divided by the standard deviation.</p_value_desc>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>SF-36</title>
        <description>Health-related Quality of Life (HRQOL) Indices (Physical/Emotional Function, Role Function, Pain, General Health, Vitality, Mental/Physical Health)HRQOL(SF-36) calculated using Quality Metric, Inc. an algorithm producing normal scores (1-100 range). With normed scoring, general population has mean=50, SD=10. For the minimum and maximum values in each of the scale ranges provided, higher values represent a better outcome.</description>
        <time_frame>Time 2 (week 8), Time 3 (week 11), and overall average for group comparisons.</time_frame>
        <population>Adjusted means of outcomes and standards error provided for T2 &amp; 3, folllowed by summary of linear mixed effects models for the outcomes for group comparisons.</population>
        <group_list>
          <group group_id="O1">
            <title>Attention Control Group</title>
            <description>weekly phone calls.
symptom assessment interview.</description>
          </group>
          <group group_id="O2">
            <title>Mindfulness Intervention</title>
            <description>Participants receive 6 weekly sessions of a home delivered mindfulness intervention.
Participants receive weekly phone calls to assess symptoms.</description>
          </group>
        </group_list>
        <measure>
          <title>SF-36</title>
          <description>Health-related Quality of Life (HRQOL) Indices (Physical/Emotional Function, Role Function, Pain, General Health, Vitality, Mental/Physical Health)HRQOL(SF-36) calculated using Quality Metric, Inc. an algorithm producing normal scores (1-100 range). With normed scoring, general population has mean=50, SD=10. For the minimum and maximum values in each of the scale ranges provided, higher values represent a better outcome.</description>
          <population>Adjusted means of outcomes and standards error provided for T2 &amp; 3, folllowed by summary of linear mixed effects models for the outcomes for group comparisons.</population>
          <units>units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Physical Function -Time 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34.94" spread="1.94"/>
                    <measurement group_id="O2" value="42.49" spread="2.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Physical Function - Time 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36.86" spread="1.94"/>
                    <measurement group_id="O2" value="43.31" spread="2.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Physical Function - Summary</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.90" spread="1.73"/>
                    <measurement group_id="O2" value="42.90" spread="1.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Physical Role Function - Time 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39.56" spread="2.22"/>
                    <measurement group_id="O2" value="41.61" spread="2.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Physical Role Function - Time 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41.82" spread="2.27"/>
                    <measurement group_id="O2" value="44.34" spread="2.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Physical Role Function - Summary</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40.69" spread="1.80"/>
                    <measurement group_id="O2" value="42.97" spread="1.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bodily Pain Time 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44.81" spread="2.52"/>
                    <measurement group_id="O2" value="51.22" spread="2.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bodily Pain Time 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45.15" spread="2.56"/>
                    <measurement group_id="O2" value="46.58" spread="2.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bodily Pain Summary</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44.93" spread="2.25"/>
                    <measurement group_id="O2" value="48.89" spread="2.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>General Health - Time 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46.05" spread="1.90"/>
                    <measurement group_id="O2" value="48.20" spread="2.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>General Health Summary</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44.59" spread="1.70"/>
                    <measurement group_id="O2" value="46.35" spread="1.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vitality Time 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44.88" spread="2.19"/>
                    <measurement group_id="O2" value="47.49" spread="2.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vitality Time 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43.37" spread="2.21"/>
                    <measurement group_id="O2" value="48.34" spread="2.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vitality Summary</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44.15" spread="2.06"/>
                    <measurement group_id="O2" value="47.92" spread="2.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Social Function - Time 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39.88" spread="2.22"/>
                    <measurement group_id="O2" value="47.54" spread="2.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Social Function - Time 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42.53" spread="2.28"/>
                    <measurement group_id="O2" value="48.97" spread="2.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Social Function - Summary</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41.20" spread="1.75"/>
                    <measurement group_id="O2" value="48.25" spread="1.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Emotional Role Function - Time 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49.28" spread="1.78"/>
                    <measurement group_id="O2" value="51.15" spread="1.93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Emotional Role Function - Time 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49.49" spread="1.82"/>
                    <measurement group_id="O2" value="51.40" spread="1.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Emotional Role Function - Summary</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49.38" spread="1.68"/>
                    <measurement group_id="O2" value="51.28" spread="1.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mental Health - Time 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49.61" spread="2.20"/>
                    <measurement group_id="O2" value="54.51" spread="2.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mental Health - Time 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48.30" spread="2.22"/>
                    <measurement group_id="O2" value="54.51" spread="2.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mental Health - Summary</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48.97" spread="2.09"/>
                    <measurement group_id="O2" value="54.52" spread="2.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Physical Overall - Time 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37.14" spread="2.05"/>
                    <measurement group_id="O2" value="42.79" spread="2.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Physical Overall - Time 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38.29" spread="2.05"/>
                    <measurement group_id="O2" value="41.66" spread="2.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Physical Overall - Summary</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37.72" spread="1.84"/>
                    <measurement group_id="O2" value="42.22" spread="1.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mental Overall - Time 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50.72" spread="2.16"/>
                    <measurement group_id="O2" value="54.27" spread="2.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mental Overall - Time 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49.84" spread="2.14"/>
                    <measurement group_id="O2" value="54.94" spread="2.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <p_value_desc>P values below 0.05 are considered statistically significant in this study.</p_value_desc>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Center for Epidemiologic Studies Depression (CES-D)</title>
        <description>The score is the sum of the 20 questions. Each item has a range of 1 - 4 for frequency of a behavior or mental state in the past week ; 1 - Rarely or none of the time (less than 1 day); 2 = Some or a little of the time (1-2 days); 3 = Occasionally or a moderate amount of time (3-4 days); 4 = Most or all of the time (5-7 days). Possible range is 0-60. There are 4 reverse-scored items (questions 4, 8, 12, and 16). A score of 16 points or more is considered depressed.</description>
        <time_frame>Time 2 (week 8), Time 3 (week 11), and overall average for group comparisons.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Attention Control Group</title>
            <description>weekly phone calls.
symptom assessment interview.</description>
          </group>
          <group group_id="O2">
            <title>Mindfulness Intervention</title>
            <description>Participants receive 6 weekly sessions of a home delivered mindfulness intervention.
Participants receive weekly phone calls to assess symptoms.</description>
          </group>
        </group_list>
        <measure>
          <title>Center for Epidemiologic Studies Depression (CES-D)</title>
          <description>The score is the sum of the 20 questions. Each item has a range of 1 - 4 for frequency of a behavior or mental state in the past week ; 1 - Rarely or none of the time (less than 1 day); 2 = Some or a little of the time (1-2 days); 3 = Occasionally or a moderate amount of time (3-4 days); 4 = Most or all of the time (5-7 days). Possible range is 0-60. There are 4 reverse-scored items (questions 4, 8, 12, and 16). A score of 16 points or more is considered depressed.</description>
          <units>units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>CESD - Time 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.70" spread="1.84"/>
                    <measurement group_id="O2" value="8.07" spread="1.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CESD - Time 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.83" spread="1.84"/>
                    <measurement group_id="O2" value="7.63" spread="1.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CESD - Summary</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.76" spread="1.68"/>
                    <measurement group_id="O2" value="7.84" spread="1.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;.05</p_value>
            <p_value_desc>P values below 0.05 are considered statistically significant in this study.</p_value_desc>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Cancer Dyspnea Scale</title>
        <description>The cancer dyspnea scale (CDS) has 12 Likert scale items ( 1 = Not at all, 5 = Very much) that ask questions about breathlessness or difficulty in breathing during the past few days. The CDS has an overall score (range 0-42) and 3 subscales that measure the amount of effort with breathing, anxiety associated with breathing, and discomfort associated with breathing.
The 3 subscales are calculated by: 1) effort (items 4+6+8+10+12) – 5 [range 0 (no dyspnea effort)-20 (worst dyspnea effort)]; 2) anxiety (items 5+7+9+11) – 4 [range 0 (no dyspnea anxiety) - 16 (worst dyspnea anxiety)]; 3) discomfort [15 – (items 1+2+3) {range 0 (no dyspnea discomfort) - 12 (worst dyspnea discomfort)}]. The total dyspnea score is derived by adding the total subscale scores. The subscale score subtractions are to make adjustments for 0 as a state of absence of dyspnea (thus total dyspnea summary scores range from 0 to 42).</description>
        <time_frame>Time 2 (week 8), Time 3 (week 11), and overall average for group comparisons.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Attention Control Group</title>
            <description>weekly phone calls.
symptom assessment interview.</description>
          </group>
          <group group_id="O2">
            <title>Mindfulness Intervention</title>
            <description>Participants receive 6 weekly sessions of a home delivered mindfulness intervention.
Participants receive weekly phone calls to assess symptoms.</description>
          </group>
        </group_list>
        <measure>
          <title>Cancer Dyspnea Scale</title>
          <description>The cancer dyspnea scale (CDS) has 12 Likert scale items ( 1 = Not at all, 5 = Very much) that ask questions about breathlessness or difficulty in breathing during the past few days. The CDS has an overall score (range 0-42) and 3 subscales that measure the amount of effort with breathing, anxiety associated with breathing, and discomfort associated with breathing.
The 3 subscales are calculated by: 1) effort (items 4+6+8+10+12) – 5 [range 0 (no dyspnea effort)-20 (worst dyspnea effort)]; 2) anxiety (items 5+7+9+11) – 4 [range 0 (no dyspnea anxiety) - 16 (worst dyspnea anxiety)]; 3) discomfort [15 – (items 1+2+3) {range 0 (no dyspnea discomfort) - 12 (worst dyspnea discomfort)}]. The total dyspnea score is derived by adding the total subscale scores. The subscale score subtractions are to make adjustments for 0 as a state of absence of dyspnea (thus total dyspnea summary scores range from 0 to 42).</description>
          <units>units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>CDS total score - Time 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.69" spread="1.10"/>
                    <measurement group_id="O2" value="4.07" spread="1.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CDS total score - Time 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.50" spread="1.10"/>
                    <measurement group_id="O2" value="3.21" spread="1.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CDS - total score - Summary</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.60" spread=".99"/>
                    <measurement group_id="O2" value="3.64" spread="1.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CDS - effort - Time 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.25" spread=".54"/>
                    <measurement group_id="O2" value="2.06" spread=".58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CDS - effort - Time 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.44" spread=".54"/>
                    <measurement group_id="O2" value="2.14" spread=".59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CDS - effort - summary</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.34" spread=".50"/>
                    <measurement group_id="O2" value="2.10" spread=".54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CDS - anxiety - Time 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".93" spread=".40"/>
                    <measurement group_id="O2" value=".79" spread=".43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CDS - anxiety - Time 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".80" spread=".40"/>
                    <measurement group_id="O2" value=".58" spread=".43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CDS - anxiety - summary</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".87" spread=".32"/>
                    <measurement group_id="O2" value=".69" spread=".34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CDS - discomfort - Time 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.80" spread=".56"/>
                    <measurement group_id="O2" value=".87" spread=".60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CDS - discomfort - Time 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.55" spread=".56"/>
                    <measurement group_id="O2" value=".16" spread=".60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CDS - discomfort - summary</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.68" spread=".48"/>
                    <measurement group_id="O2" value=".51" spread=".52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <p_value_desc>P values below 0.05 are considered statistically significant in this study.</p_value_desc>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Worry (Cancer-related and General)</title>
        <description>Both cancer-related and general worry were measured with 3 item scales. Cancer-related worry had three statements asking about level of worry related to diagnosis, treatment, and worry interference using a 1 = &quot;not at all&quot; to 5 = &quot;most or all the time&quot; scale, range 3-15. Items are summed. General worry used an abbreviated brief Penn State Worry questionnaire with 3 statements that measure how typical that statements are in describing the person. Uses a 3 item scale with 1 = &quot;not at all typical&quot; to 5 = &quot;very typical&quot;. the range is 3-15. Items are summed.</description>
        <time_frame>Time 2 (week 8), Time 3 (week 11), and overall average for group comparisons.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Attention Control Group</title>
            <description>weekly phone calls.
symptom assessment interview.</description>
          </group>
          <group group_id="O2">
            <title>Mindfulness Intervention</title>
            <description>Participants receive 6 weekly sessions of a home delivered mindfulness intervention.
Participants receive weekly phone calls to assess symptoms.</description>
          </group>
        </group_list>
        <measure>
          <title>Worry (Cancer-related and General)</title>
          <description>Both cancer-related and general worry were measured with 3 item scales. Cancer-related worry had three statements asking about level of worry related to diagnosis, treatment, and worry interference using a 1 = &quot;not at all&quot; to 5 = &quot;most or all the time&quot; scale, range 3-15. Items are summed. General worry used an abbreviated brief Penn State Worry questionnaire with 3 statements that measure how typical that statements are in describing the person. Uses a 3 item scale with 1 = &quot;not at all typical&quot; to 5 = &quot;very typical&quot;. the range is 3-15. Items are summed.</description>
          <units>units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Cancer-related worry - Time 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.26" spread=".58"/>
                    <measurement group_id="O2" value="6.28" spread=".62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cancer-related worry - Time 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.88" spread=".58"/>
                    <measurement group_id="O2" value="6.06" spread=".62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cancer-related worry - Summary</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.07" spread=".49"/>
                    <measurement group_id="O2" value="6.17" spread=".53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>General worry - Time 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.89" spread=".52"/>
                    <measurement group_id="O2" value="5.41" spread=".56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>General worry - Time 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.88" spread=".58"/>
                    <measurement group_id="O2" value="6.06" spread=".62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>General worry - Summary</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.07" spread=".49"/>
                    <measurement group_id="O2" value="6.17" spread=".53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <p_value_desc>P values below 0.05 are considered statistically significant in this study.</p_value_desc>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Pittsburgh Sleep Symptom Questionnaire-Insomnia (PSSQ_I)</title>
        <description>The PSSQ_I has 13 self rated questions. The first 5 items, used to determine sleep quality (presence; frequency of insomnia problems) are rated [0 = never to 5 = always, 5-7 days per week; (range 0-25)] and items 6 to 13 are aimed at identifying the degree of interference experienced from sleep impairment (rated 0=not at all to 4=extremely on Likert scale; range 0 - 32).</description>
        <time_frame>Time 2 (week 8), Time 3 (week 11), and overall average for group comparisons.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Symptom Assessment</title>
            <description>6 weeks of symptom assessment phone calls.
symptom assessment: attention control receives a weekly symptom assessment phone interview for 6 weeks.</description>
          </group>
          <group group_id="O2">
            <title>Mindfulness Intervention</title>
            <description>Participants receive 6 weeks of the home-based mindfulness intervention, and weekly symptom assessment phone calls.
symptom assessment: attention control receives a weekly symptom assessment phone interview for 6 weeks.
Mindfulness Intervention: Participants will receive a weekly home-based mindfulness intervention, and symptom assessment phone interviews for 6 weeks.</description>
          </group>
        </group_list>
        <measure>
          <title>Pittsburgh Sleep Symptom Questionnaire-Insomnia (PSSQ_I)</title>
          <description>The PSSQ_I has 13 self rated questions. The first 5 items, used to determine sleep quality (presence; frequency of insomnia problems) are rated [0 = never to 5 = always, 5-7 days per week; (range 0-25)] and items 6 to 13 are aimed at identifying the degree of interference experienced from sleep impairment (rated 0=not at all to 4=extremely on Likert scale; range 0 - 32).</description>
          <units>units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>PSSQ_I Quality -Time 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.62" spread="1.95"/>
                    <measurement group_id="O2" value="8.71" spread="2.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PSSQ_I Quality-Time 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.93" spread="1.99"/>
                    <measurement group_id="O2" value="8.17" spread="2.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PSSQ_I Quality- Overall</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.76" spread="1.75"/>
                    <measurement group_id="O2" value="8.38" spread="1.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PSSQ_I Interference- Time 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.45" spread="1.47"/>
                    <measurement group_id="O2" value="5.99" spread="1.55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PSSQ_I Interference- Time 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.26" spread="1.54"/>
                    <measurement group_id="O2" value="6.28" spread="1.55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PSSQ_I Interference- Overall</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.80" spread="1.25"/>
                    <measurement group_id="O2" value="6.13" spread="1.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <p_value_desc>P values below 0.05 are considered statistically significant in this study.</p_value_desc>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Baseline Values for All Measures.</title>
        <description>Description of all measures are described elsewhere. Provided are the means and standard deviations for baseline comparisons.</description>
        <time_frame>Baseline.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Symptom Assessment</title>
            <description>weekly phone calls.
symptom assessment: attention control group</description>
          </group>
          <group group_id="O2">
            <title>Mindfulness Intervention</title>
            <description>Participants will receive 6 weeks of home-based mindfulness intervention.
Mindfulness Intervention: Participants will receive a weekly home-based mindfulness intervention.
Participants also receive weekly symptom assessment phone interview.</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline Values for All Measures.</title>
          <description>Description of all measures are described elsewhere. Provided are the means and standard deviations for baseline comparisons.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>MDASI Symptom Severity (range 0-130)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29.25" spread="19.18"/>
                    <measurement group_id="O2" value="35" spread="21.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>MDASI Symptom Interference (range 0-50)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.15" spread="16.41"/>
                    <measurement group_id="O2" value="21.25" spread="16.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HRQOL -Physical Function (range 0-100)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.25" spread="10.17"/>
                    <measurement group_id="O2" value="37.73" spread="8.90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HRQOL - Physical Role Function (range 0-100)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40.31" spread="10.47"/>
                    <measurement group_id="O2" value="38.97" spread="9.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HRQOL - Bodily Pain (range 0-100)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="47.36" spread="12.29"/>
                    <measurement group_id="O2" value="41.96" spread="9.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HRQOL - General Health (range 0-100)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46.43" spread="11.66"/>
                    <measurement group_id="O2" value="41.89" spread="11.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HRQOL - Vitality (range 0-100)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45.91" spread="11.96"/>
                    <measurement group_id="O2" value="42.2" spread="7.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HRQOL - Social Function (range 0-100)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="47.56" spread="10.72"/>
                    <measurement group_id="O2" value="41.55" spread="11.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HRQOL - Emotional Function(range 0-100)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="47.12" spread="12.75"/>
                    <measurement group_id="O2" value="46.77" spread="11.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HRQOL - Mental Health (range 0-100)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49.56" spread="10.13"/>
                    <measurement group_id="O2" value="45.37" spread="10.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HRQOL - Physical Summary (range 0-100)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39.17" spread="10.43"/>
                    <measurement group_id="O2" value="37.83" spread="8.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HRQOL - Mental Summary (range 0-100)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51.82" spread="12.23"/>
                    <measurement group_id="O2" value="47.33" spread="11.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CESD - Depression (range 0-60)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.35" spread="8.27"/>
                    <measurement group_id="O2" value="15.9" spread="10.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CDS - Overall Dyspnea (range 0-42)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.85" spread="8.86"/>
                    <measurement group_id="O2" value="7.05" spread="6.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CDS - Effort (range 0-20)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.85" spread="4.98"/>
                    <measurement group_id="O2" value="4.45" spread="4.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CDS - Anxiety (range 0-16)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.55" spread="2.72"/>
                    <measurement group_id="O2" value=".85" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CDS - Discomfort (range 0-12)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.45" spread="2.63"/>
                    <measurement group_id="O2" value="1.75" spread="1.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Worry - General (range 3-15)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.55" spread="3.09"/>
                    <measurement group_id="O2" value="7.35" spread="4.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Worry - Cancer-related (range 3-15)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.45" spread="3.63"/>
                    <measurement group_id="O2" value="9.70" spread="3.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PSSQ_I Sleep quality (range 0-25)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.65" spread="7.53"/>
                    <measurement group_id="O2" value="14.47" spread="6.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PSSQ_I Sleep interference (range 0-32)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.37" spread="6.18"/>
                    <measurement group_id="O2" value="10.63" spread="8.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <p_value_desc>P values above 0.05 are considered statistically insignificant in this study.</p_value_desc>
            <method>Descriptive statistics for outcomes</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 year.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Symptom Assessment</title>
          <description>weekly phone calls.
symptom assessment: attention control group</description>
        </group>
        <group group_id="E2">
          <title>Mindfulness Intervention</title>
          <description>Participants will receive 6 weeks of home-based mindfulness intervention.
Mindfulness Intervention: Participants will receive a weekly home-based mindfulness intervention.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Rebecca H. Lehto, PhD, Assistant Professor</name_or_title>
      <organization>Michigan State University College of Nursing</organization>
      <phone>517-353-4757</phone>
      <email>rebecca.lehto@hc.msu.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

